Cytomegalovirus ("CMV") Vaccine Candidate
Автор: VBI Vaccines Inc.
Загружено: 5 авг. 2014 г.
Просмотров: 2 716 просмотров
VBI is developing a prophylactic vaccine to prevent cytomegalovirus (“CMV”) infection. CMV is a leading cause of prenatal developmental delays. VBI has completed work for GMP manufacturing of its lead candidate for use in Phase I trials. VBI expects to evaluate safety, tolerability, and also immunological proof of concept in humans during Phase I trials by measuring CMV neutralizing antibodies in fibroblasts and epithelial cells.
To learn more about VBI's CMV Vaccine Program, visit: https://www.vbivaccines.com/cmv/

Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: